NCT07505732Not yet recruiting
Information-providing Chatbot
The Development and Evaluation of a Co-designed, AI-based Information-providing Chatbot for Sarcoma Patients: A Pilot Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 1 Apr 2026
Brief summary (registry, in English)
This study aims to develop and examine the feasibility and preliminary effectiveness of an AI-based sarcoma chatbot building on ChatGPT (ASCC) to address the information needs of sarcoma patients. We hypothesized: 1) the ASCC will demonstrate good usability; 2) the study will be feasible in terms of all feasibility indicators; 3) the experimental group will report improved satisfaction and self-efficacy, decreased anxiety and stress than the control groups upon completion of the intervention. The ASCC will be developed using a co-design approach. A pilot randomized controlled trial will then be conducted in the three oncology wards of collaborative hospitals. Seventy-eight sarcoma patients will be recruited and randomized to the experimental group (n=39) and the control group (n=39). The experimental group will use the ASCC available 24/7 via voice or text for disease-related questions for one month while the control group will receive usual care.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- First submitted
- 18 Nov 2025
- Start date
- 1 Apr 2027
- Primary completion date
- 31 Jul 2028
- Lead sponsor
- The Hong Kong Polytechnic University
- Diseases
- Sarcoma
- NCT number
- NCT07505732
What you commit to
- Study type: Interventional
- Planned participants: 78
- From 1 Apr 2027 to the primary completion date, 31 Jul 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- (1) patients with unstable physical or mental conditions;
- (4) mental health disorders documented by the medical system
Other
- (2) inability to communicate logically;
- (3) using chatbots (e.g., ChatGPT, Deepseek) for sarcoma information in the last month;
Who the study is looking for
- (1) diagnosed with soft tissue sarcoma;
- (2) receiving active treatment at any stage;
- (3) aged≥18 years;
- (4) able to speak Cantonese, Mandarin and English;
- (5) access to an electronic device enabling ASCC use
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.